Cris Loiren Rodriguez

Array ( [id] => 10399451 [patent_doc_number] => 20150284459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'METHODS FOR MODULATING IMMUNE RESPONSES DURING CHRONIC IMMUNE CONDITIONS BY TARGETING IL-27 INDUCED PATHWAYS' [patent_app_type] => utility [patent_app_number] => 14/437354 [patent_app_country] => US [patent_app_date] => 2013-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 52417 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15978031 [patent_doc_number] => 10669324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => Vector encoding an Fc gamma receptor IIB protein and composition of the encoded protein [patent_app_type] => utility [patent_app_number] => 14/439493 [patent_app_country] => US [patent_app_date] => 2013-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12820 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11685001 [patent_doc_number] => 09683036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-20 [patent_title] => 'Humanized anti-IL-20 antibody and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/065950 [patent_app_country] => US [patent_app_date] => 2013-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7846 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14065950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10474836 [patent_doc_number] => 20150359853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES' [patent_app_type] => utility [patent_app_number] => 14/436523 [patent_app_country] => US [patent_app_date] => 2013-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 110800 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10354965 [patent_doc_number] => 20150239970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'Stable, Low Viscosity Antibody Formulation' [patent_app_type] => utility [patent_app_number] => 14/437585 [patent_app_country] => US [patent_app_date] => 2013-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17349 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338859 [patent_doc_number] => 20140065641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'METHOD OF MEASURING THE DEGREE OF NON-INFLAMMATORY STRESS RESPONSE' [patent_app_type] => utility [patent_app_number] => 14/047698 [patent_app_country] => US [patent_app_date] => 2013-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18139 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14047698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960402 [patent_doc_number] => 20140363430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'Activatable Antibodies that Bind Interleukin-6 Receptor and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/036973 [patent_app_country] => US [patent_app_date] => 2013-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 59381 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14036973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9306058 [patent_doc_number] => 20140044732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17F' [patent_app_type] => utility [patent_app_number] => 14/035053 [patent_app_country] => US [patent_app_date] => 2013-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14821 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14035053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9383441 [patent_doc_number] => 20140086922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'ANTI-IL-12/IL-23 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/030147 [patent_app_country] => US [patent_app_date] => 2013-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 59149 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14030147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10362843 [patent_doc_number] => 20150247848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'MATERIAL AND METHODS FOR DIAGNOSING AND TREATING KAWASAKI DISEASE AND KLS' [patent_app_type] => utility [patent_app_number] => 14/427576 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10948 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9396509 [patent_doc_number] => 20140093915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'IL-18 RECEPTOR ANTIGEN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/017014 [patent_app_country] => US [patent_app_date] => 2013-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 28484 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14017014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9173934 [patent_doc_number] => 20130315919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'ANTI-IL-22RA ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/960556 [patent_app_country] => US [patent_app_date] => 2013-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82995 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9175218 [patent_doc_number] => 20130317203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'Anti-IL-6 Receptor Antibody' [patent_app_type] => utility [patent_app_number] => 13/959489 [patent_app_country] => US [patent_app_date] => 2013-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 60085 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13959489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9295205 [patent_doc_number] => 20140038839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'HUMAN IL-17 PRODUCING HELPER T CELL DETECTION METHOD' [patent_app_type] => utility [patent_app_number] => 13/952363 [patent_app_country] => US [patent_app_date] => 2013-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10454 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10290980 [patent_doc_number] => 20150175979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'PTPRS AND PROTEOGLYCANS IN AUTOIMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 14/416839 [patent_app_country] => US [patent_app_date] => 2013-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22816 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10895709 [patent_doc_number] => RE045313 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2014-12-30 [patent_title] => 'Exendin variant peptides' [patent_app_type] => reissue [patent_app_number] => 13/944735 [patent_app_country] => US [patent_app_date] => 2013-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28467 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9147821 [patent_doc_number] => 20130302344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'METHODS AND MEDICAMENTS FOR THE TREATMENT OF GOUT OR PSEUDOGOUT' [patent_app_type] => utility [patent_app_number] => 13/943638 [patent_app_country] => US [patent_app_date] => 2013-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 8271 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11916550 [patent_doc_number] => 09784728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-10 [patent_title] => 'Fluorescent fusion polypeptide' [patent_app_type] => utility [patent_app_number] => 14/412513 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8997 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9869061 [patent_doc_number] => 08956832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Cells expressing anti-GD2 antibodies and methods related thereto' [patent_app_type] => utility [patent_app_number] => 13/933594 [patent_app_country] => US [patent_app_date] => 2013-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 30 [patent_no_of_words] => 32764 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13933594 [rel_patent_id] =>[rel_patent_doc_number] =>)